The private sector plays a crucial role in translating academic research into marketable products. Companies invest in nanotechnology startups and joint ventures to leverage new discoveries and bring them to market. Venture capital firms and corporate investors provide not only funding but also expertise in commercialization, helping to bridge the gap between research and practical applications. These investments are particularly important for scaling up production and conducting clinical trials in fields like nanomedicine.
